Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:300204 Staidson (Beijing) Biopharmaceuticals Co Ltd SZSE:300204
46 GF Score
Price ¥20.94
GF Value ¥4.34
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Staidson (Beijing) Biopharmaceuticals Co Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

SZSE:300204 vs VRTX, REGN, MRNA: Short Percentage of Float Comparison

For the Biotechnology subindustry, Staidson (Beijing) Biopharmaceuticals Co's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Staidson (Beijing) Biopharmaceuticals Co Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Staidson (Beijing) Biopharmaceuticals Co's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Staidson (Beijing) Biopharmaceuticals Co's Short Percentage of Float falls into.


SZSE:300204
46GF Score
Staidson (Beijing) Biopharmaceuticals Co Ltd SZSE:300204
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Staidson (Beijing) Biopharmaceuticals Co (SZSE:300204) Overvalued in 2026?

Based on GuruFocus' analysis, Staidson (Beijing) Biopharmaceuticals Co stock appears to be overvalued. The current stock price of ¥20.94 is trading 382.5% above its estimated GF Value™ of ¥4.34. GuruFocus considers Staidson (Beijing) Biopharmaceuticals Co to be Significantly Overvalued.

Key valuation signals for SZSE:300204:

  • Short Percentage of Float:
  • GF Value™: ¥4.34 vs. price of ¥20.94 (382.5% above fair value)
  • GF Score™: 46/100 with 4 warning signs

No single metric tells the full story. See the SZSE:300204 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Staidson (Beijing) Biopharmaceuticals Co Business Description

Address Rongjing Dong Street, No 5 Beijing Economic and Technological Development Zone, Beijing, CHN, 100176
Staidson (Beijing) Biopharmaceuticals Co Ltd is a pharmaceutical company mainly engaged in the research, development, production, and sale of biological products in China. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin.
46GF Score

Get the complete analysis for SZSE:300204

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.94
Price
¥4.34
GF Value